Neuronetics Stock Market Value
| STIM Stock | USD 2.13 0.07 3.18% |
| Symbol | Neuronetics |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth 1.013 | Return On Assets | Return On Equity |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Neuronetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neuronetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neuronetics.
| 10/26/2025 |
| 01/24/2026 |
If you would invest 0.00 in Neuronetics on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Neuronetics or generate 0.0% return on investment in Neuronetics over 90 days. Neuronetics is related to or competes with Prenetics Global, Nyxoah, Atlantic International, OmniAb, Perspective Therapeutics, OraSure Technologies, and Profound Medical. Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients w... More
Neuronetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neuronetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neuronetics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 28.95 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 10.55 |
Neuronetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neuronetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neuronetics' standard deviation. In reality, there are many statistical measures that can use Neuronetics historical prices to predict the future Neuronetics' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | 0.1193 |
Neuronetics January 24, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | 0.1293 | |||
| Mean Deviation | 5.12 | |||
| Coefficient Of Variation | (7,365) | |||
| Standard Deviation | 6.62 | |||
| Variance | 43.81 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | 0.1193 | |||
| Maximum Drawdown | 28.95 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 10.55 | |||
| Skewness | 0.3237 | |||
| Kurtosis | 0.7213 |
Neuronetics Backtested Returns
Neuronetics has Sharpe Ratio of -0.0485, which conveys that the firm had a -0.0485 % return per unit of risk over the last 3 months. Neuronetics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neuronetics' insignificant Risk Adjusted Performance, mean deviation of 5.12, and Standard Deviation of 6.62 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.84, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Neuronetics are expected to decrease at a much lower rate. During the bear market, Neuronetics is likely to outperform the market. At this point, Neuronetics has a negative expected return of -0.33%. Please make sure to verify Neuronetics' maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Neuronetics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.71 |
Almost perfect reverse predictability
Neuronetics has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Neuronetics time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neuronetics price movement. The serial correlation of -0.71 indicates that around 71.0% of current Neuronetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.71 | |
| Spearman Rank Test | -0.68 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Neuronetics Correlation, Neuronetics Volatility and Neuronetics Alpha and Beta module to complement your research on Neuronetics. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Neuronetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.